Hester Biosciences Ltd Nine Monthly Results

Gross Sales

229.18

225.29

198.79

178.54

150.16

Excise Duty

0

0

0

0

0

Net Sales

229.18

225.29

198.79

178.54

150.16

Other Operating Income

0

0

0

0

0

Other Income

13.66

10.62

16.08

6.55

2.21

Total Income

242.84

235.91

214.87

185.09

152.37

Total Expenditure

187.31

187.56

159.86

128.88

101.28

PBIDT

55.54

48.35

55.01

56.21

51.09

Interest

7.08

12.84

7.95

2.56

5.17

PBDT

48.45

35.52

47.06

53.64

45.92

Depreciation

12.63

13.43

15.33

11.45

9.68

Minority Interest Before NP

0

0

0

0

0

Tax

8.11

6.81

8.98

12.66

11.76

Deferred Tax

0.43

0.51

0.44

-0.95

-0.13

Reported Profit After Tax

27.29

14.77

22.32

30.48

24.6

Minority Interest After NP

1.09

0.83

0.23

-1.12

-0.14

Net Profit after Minority Interest

26.2

13.94

22.1

31.6

24.74

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

26.2

13.94

22.1

31.6

24.74

EPS (Unit Curr.)

32.07

17.36

26.24

35.83

28.92

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

8.51

8.51

8.51

8.51

8.51

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

24.23

21.46

27.67

31.48

34.02

PBDTM(%)

21.14

15.76

23.67

30.04

30.58

PATM(%)

11.9

6.55

11.22

17.07

16.38